{"id":"93349e75-059a-510b-94d7-fcaefd09d056","stable_key":"252872b9-233f-5692-b72b-c8930ba0cfb7:sil-two-sources-of-the-messenger","predicate":"produces","statement":"In cardiac myocytes cyclic GMP is produced by soluble and particulate guanylyl cyclases, the former stimulated by nitric oxide and the latter by natriuretic peptides, and is hydrolyzed to inactive 5-GMP by cyclic GMP phosphodiesterases, cyclic GMP and protein kinase G modulate cardiac contractility, hypertrophy and remodeling and exert cardioprotection, recent studies have revealed that cyclic GMP degradation controlled by phosphodiesterases plays a critical role in the physiological action of cyclic GMP, and several clinical trials are ongoing including a large multicenter trial led by the NIH evaluating sildenafil efficacy in heart failure with preserved ejection fraction.","claim_class":"observational","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"7af82790-d7cf-5a3c-b925-66a8fa0501a3","mechanism_event_label":"The messenger has a second source that answers to natriuretic peptides rather than nitric oxide.","subject":{"id":"b61f3d0b-5920-5636-8d73-7baa4777f03f","slug":"particulate-guanylate-cyclase","display_name":"Membrane-bound particulate guanylate cyclase and other non-nitric-oxide sources of cyclic GMP","entity_type_key":"protein_family"},"object":{"id":"6d2f509b-3a5b-5a38-b3e7-b148581edec9","slug":"cgmp","display_name":"Cyclic guanosine monophosphate","entity_type_key":"small_molecule"},"evidence_count":1,"mechanism_event":{"id":"7af82790-d7cf-5a3c-b925-66a8fa0501a3","stable_key":"252872b9-233f-5692-b72b-c8930ba0cfb7:sil-two-sources-of-the-messenger-event","event_type":"observed_intervention","label":"The messenger has a second source that answers to natriuretic peptides rather than nitric oxide.","description":"In cardiac myocytes cyclic GMP is produced by soluble and particulate guanylyl cyclases, the former stimulated by nitric oxide and the latter by natriuretic peptides, and is hydrolyzed to inactive 5-GMP by cyclic GMP phosphodiesterases, cyclic GMP and protein kinase G modulate cardiac contractility, hypertrophy and remodeling and exert cardioprotection, recent studies have revealed that cyclic GMP degradation controlled by phosphodiesterases plays a critical role in the physiological action of cyclic GMP, and several clinical trials are ongoing including a large multicenter trial led by the NIH evaluating sildenafil efficacy in heart failure with preserved ejection fraction.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"ebc029a2-c8ae-56e8-a864-aeb1afa2e10c","slug":"natriuretic-peptides","display_name":"Natriuretic peptides","entity_type_key":"peptide"},"role":"alternative_stimulus","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"bd3ea5e4-0ed9-5ad3-ab2a-42435337fa85","slug":"human-sgc-alpha1-beta1","display_name":"Human soluble guanylate cyclase alpha1-beta1 heterodimer","entity_type_key":"protein_complex"},"role":"nitric_oxide_route","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"35d34766-3d30-5f71-9228-34bf184886d3","slug":"cardiac-myocyte","display_name":"Cardiac myocyte","entity_type_key":"cell_type"},"role":"studied_cell","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"4c288678-9116-5460-a9a9-8f7e1f253430","slug":"prkg1","display_name":"cGMP-dependent protein kinase I","entity_type_key":"protein"},"role":"downstream_kinase","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"3d39054f-649d-5b50-ba42-92d743e23824","slug":"cgmp-hydrolysis","display_name":"Hydrolysis of cyclic GMP to 5-guanosine monophosphate","entity_type_key":"cellular_process"},"role":"opposing_reaction","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"0be8b435-6b8a-592c-bd4c-c0efd9481a97","slug":"pde5-family","display_name":"Phosphodiesterase 5 family","entity_type_key":"protein_family"},"role":"degrading_enzyme","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""},{"entity":{"id":"b61f3d0b-5920-5636-8d73-7baa4777f03f","slug":"particulate-guanylate-cyclase","display_name":"Membrane-bound particulate guanylate cyclase and other non-nitric-oxide sources of cyclic GMP","entity_type_key":"protein_family"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":6,"notes":""},{"entity":{"id":"6d2f509b-3a5b-5a38-b3e7-b148581edec9","slug":"cgmp","display_name":"Cyclic guanosine monophosphate","entity_type_key":"small_molecule"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":7,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/sildenafil-research/22785374.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"14560978d3bfa37c665443c993d21b9c4a0e287c6c8c45672ee35ed55f0c6094\", \"start_char\": 0, \"end_char\": 1262, \"text_sha256\": \"14560978d3bfa37c665443c993d21b9c4a0e287c6c8c45672ee35ed55f0c6094\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Review of cyclic GMP and protein kinase G signal regulation in the cardiac myocyte","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Sources and degradation of cyclic GMP in the myocyte, and phosphodiesterase type 5 inhibition across cardiac pathologies","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"A review written while the definitive trial was still running, and it names that trial as the test of its own thesis.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Sildenafil research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from its N-desmethyl metabolite and its target enzyme from the homologous retinal PDE6.","comparator":null,"unit":null,"notes":"","entity":{"slug":"sildenafil","display_name":"Sildenafil","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Animal and human","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The messenger has a second source that answers to natriuretic peptides rather than nitric oxide.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[sil-p22785374] Cyclic GMP-dependent signaling in cardiac myocytes. (2012). https://pubmed.ncbi.nlm.nih.gov/22785374/ DOI: 10.1253/circj.cj-12-0664","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Cardiac myocyte","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"ef92a5ec-acaa-5f11-95ca-bff6c52d399e","evidence_kind":"source_excerpt","locator":"Lines 613-624","start_line":613,"end_line":624,"excerpt":"### sil-two-sources-of-the-messenger\nIn cardiac myocytes cyclic GMP is produced by soluble and particulate guanylyl cyclases, the former stimulated by nitric oxide and the latter by natriuretic peptides, and is hydrolyzed to inactive 5-GMP by cyclic GMP phosphodiesterases, cyclic GMP and protein kinase G modulate cardiac contractility, hypertrophy and remodeling and exert cardioprotection, recent studies have revealed that cyclic GMP degradation controlled by phosphodiesterases plays a critical role in the physiological action of cyclic GMP, and several clinical trials are ongoing including a large multicenter trial led by the NIH evaluating sildenafil efficacy in heart failure with preserved ejection fraction.\nCondition category: normal\nnutrient_topic: Sildenafil research collection; topical membership is not evidence of a direct clinical effect, and the drug is recorded separately from its N-desmethyl metabolite and its target enzyme from the homologous retinal PDE6.\nplain_language: The messenger has a second source that answers to natriuretic peptides rather than nitric oxide.\norganism: Animal and human\ntissue_or_cell_type: Cardiac myocyte\nexperimental_model: Review of cyclic GMP and protein kinase G signal regulation in the cardiac myocyte\nlimitations: A review written while the definitive trial was still running, and it names that trial as the test of its own thesis.\nexposure: Sources and degradation of cyclic GMP in the myocyte, and phosphodiesterase type 5 inhibition across cardiac pathologies\nevidence_span: {\"source_cache\": \"artifacts/sildenafil-research/22785374.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"14560978d3bfa37c665443c993d21b9c4a0e287c6c8c45672ee35ed55f0c6094\", \"start_char\": 0, \"end_char\": 1262, \"text_sha256\": \"14560978d3bfa37c665443c993d21b9c4a0e287c6c8c45672ee35ed55f0c6094\"}\n[sil-p22785374] Cyclic GMP-dependent signaling in cardiac myocytes. (2012). https://pubmed.ncbi.nlm.nih.gov/22785374/ DOI: 10.1253/circj.cj-12-0664","model_system":"Review of cyclic GMP and protein kinase G signal regulation in the cardiac myocyte","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [sil-p22785374] Cyclic GMP-dependent signaling in cardiac myocytes. (2012). https://pubmed.ncbi.nlm.nih.gov/22785374/ DOI: 10.1253/circj.cj-12-0664","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"c6c2a590-1f8f-5fac-b2c7-3aae0440b9fd","stable_key":"import-252872b9-233f-5692-b72b-c8930ba0cfb7","title":"Sildenafil: the enzyme it occupies instead of the substrate, why it cannot start a signal it can only preserve, the organic nitrate interaction that follows from that, the homologous retinal enzyme ten-fold away, and the pulmonary circulation where the same mechanism became a second indication (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"bc81793d20d20d2eaad9cb530b70695d8d8778a3d7136e24715ac3369b939953","revision_id":"301732e1-2446-5b67-b3bd-580164b85b05","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}